相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans
Andreas Stadlbauer et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study
Maria del Mar Alvarez-Torres et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)
Response Assessment in Neuro-Oncology Criteria for Gliomas: Practical Approach Using Conventional and Advanced Techniques
D. J. Leao et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2020)
Clinical Imaging for Diagnostic Challenges in the Management of Gliomas: A Review
Alipi V. Bonm et al.
JOURNAL OF NEUROIMAGING (2020)
Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification
K. Ina Ly et al.
NEUROLOGIC CLINICS (2020)
fMRI-Targeted High-Angular Resolution Diffusion MR Tractography to Identify Functional Language Tracts in Healthy Controls and Glioma Patients
Francesco Sanvito et al.
FRONTIERS IN NEUROSCIENCE (2020)
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2020)
Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection
Ashish H. Shah et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma
Christina Jackson et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Deciphering the complex role of thrombospondin-1 in glioblastoma development
Thomas Daubon et al.
NATURE COMMUNICATIONS (2019)
Multi-Channel 3D Deep Feature Learning for Survival Time Prediction of Brain Tumor Patients Using Multi-Modal Neuroimages
Dong Nie et al.
SCIENTIFIC REPORTS (2019)
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors
Marco Riva et al.
WORLD NEUROSURGERY (2019)
Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research
A. Lasocki et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2019)
Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients
Norbert Galldiks et al.
NEURO-ONCOLOGY (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas
Yasukazu Fukuya et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Artificial Intelligence in the Management of Glioma: Era of Personalized Medicine
Houman Sotoudeh et al.
FRONTIERS IN ONCOLOGY (2019)
Longitudinal molecular trajectories of diffuse glioma in adults
Floris P. Barthel et al.
NATURE (2019)
18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma
Francesco Cicone et al.
ANNALS OF NUCLEAR MEDICINE (2019)
Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases
J. Seoane et al.
ANNALS OF ONCOLOGY (2019)
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Ian Law et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
The role of frameless stereotactic biopsy in contemporary neuro-oncology: molecular specifications and diagnostic yield in biopsied glioma patients
Marius Marc-Daniel Mader et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastoma
Matthias Holdhoff et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival
Flora John et al.
NEURO-ONCOLOGY (2019)
Supratotal resection in glioma: a systematic review
Charles N. de Leeuw et al.
NEURO-ONCOLOGY (2019)
Frameless stereotactic biopsy for precision neurosurgery: diagnostic value, safety, and accuracy
Tommaso Sciortino et al.
ACTA NEUROCHIRURGICA (2019)
C-11-MET PET/MRI for detection of recurrent glioma
C. Deuschl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Static and dynamic F-18-FET PET for the characterization of gliomas defined by IDH and 1p/19q status
Antoine Verger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics
Melissa A. Prah et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Identification of time-to-peak on dynamic F-18-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma
Bogdana Suchorska et al.
NEURO-ONCOLOGY (2018)
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
Jann N. Sarkaria et al.
NEURO-ONCOLOGY (2018)
Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy
Francesca Branzoli et al.
NEURO-ONCOLOGY (2018)
Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
Abdul W. Abbasi et al.
CLINICAL NEURORADIOLOGY (2018)
Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome
Aikaterini Kotrotsou et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature
Named Akbari et al.
NEURO-ONCOLOGY (2018)
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma
Benjamin M. Ellingson et al.
NEURO-ONCOLOGY (2018)
Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma
Andreas Stadlbauer et al.
NEURO-ONCOLOGY (2018)
2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data
Chong Hyun Suh et al.
NEURO-ONCOLOGY (2018)
Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images
Nicoletta Anzalone et al.
RADIOLOGY (2018)
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate
Ovidiu C. Andronesi et al.
NATURE COMMUNICATIONS (2018)
Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1
Saima Rathore et al.
SCIENTIFIC REPORTS (2018)
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Johanna Klughammer et al.
NATURE MEDICINE (2018)
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study
Federico Pessina et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis
Praneil Patel et al.
NEURO-ONCOLOGY (2017)
Radiogenomics to characterize regional genetic heterogeneity in glioblastoma
Leland S. Hu et al.
NEURO-ONCOLOGY (2017)
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma
Egesta Lopci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas
A. Verger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience
Federico Pessina et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Imaging Correlates of Adult Glioma Genotypes
Marion Smits et al.
RADIOLOGY (2017)
Less Invasive Phenotype Found in Isocitrate Dehydrogenase-mutated Glioblastomas than in Isocitrate Dehydrogenase Wild-Type Glioblastomas: A Diffusion-Tensor Imaging Study
Stephen J. Price et al.
RADIOLOGY (2017)
The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors
Kevin Boye et al.
NATURE COMMUNICATIONS (2017)
Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials
Benjamin M. Ellingson et al.
CLINICAL CANCER RESEARCH (2017)
Functional MRI for Surgery of Gliomas
Antonella Castellano et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2017)
Quantitative glioma grading using transformed gray-scale invariant textures of MRI
Kevin Li-Chun Hsieh et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2017)
Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma
Mark S. Shiroishi et al.
NEURO-ONCOLOGY (2016)
Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection
Florian Ringel et al.
NEURO-ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell–Derived Experimental Glioblastomas
L.S. Politi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Progress in neuro-imaging of brain tumors
Antonella Castellano et al.
CURRENT OPINION IN ONCOLOGY (2016)
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma
Changho Choi et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L. Albert et al.
NEURO-ONCOLOGY (2016)
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial
Bogdana Suchorska et al.
NEURO-ONCOLOGY (2016)
MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma
Philipp Kickingereder et al.
RADIOLOGY (2016)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
Association of the Extent of Resection With Survival in Glioblastoma A Systematic Review and Meta-analysis
Timothy J. Brown et al.
JAMA ONCOLOGY (2016)
T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status
J. Arevalo-Perez et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Magnetic Resonance (MR) Metabolic Imaging in Glioma
Myriam M. Chaumeil et al.
BRAIN PATHOLOGY (2015)
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada et al.
LANCET ONCOLOGY (2015)
Toward precision medicine in glioblastoma: the promise and the challenges
Michael D. Prados et al.
NEURO-ONCOLOGY (2015)
Genomics of Brain Tumor Imaging
Whitney B. Pope
NEUROIMAGING CLINICS OF NORTH AMERICA (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities
Haruka Itakura et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Principles of T2*- Weighted Dynamic Susceptibility Contrast MRI Technique in Brain Tumor Imaging
Mark S. Shiroishi et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients
Sabina Eigenbrod et al.
ACTA NEUROCHIRURGICA (2014)
Utility of Diffusion Tensor Imaging in Evaluation of the Peritumoral Region in Patients with Primary and Metastatic Brain Tumors
E. J. Sternberg et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
Low-grade glioma management: a contemporary surgical approach
Marco Riva et al.
CURRENT OPINION IN ONCOLOGY (2014)
Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery
Nicholas F. Marko et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A neurocentric perspective on glioma invasion
Vishnu Anand Cuddapah et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
Kaisorn L. Chaichana et al.
NEURO-ONCOLOGY (2014)
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
Jason Beiko et al.
NEURO-ONCOLOGY (2014)
Tailoring neurophysiological strategies with clinical context enhances resection and safety and expands indications in gliomas involving motor pathways
Lorenzo Bello et al.
NEURO-ONCOLOGY (2014)
Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor
Rajan Jain et al.
RADIOLOGY (2014)
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma
Pierina Navarria et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review
Anna K. Heye et al.
NEUROIMAGE-CLINICAL (2014)
Perfusion MRI: The Five Most Frequently Asked Technical Questions
Marco Essig et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy
F. -W. Kreth et al.
ANNALS OF ONCOLOGY (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Value of 11C-methionine PET in imaging brain tumours and metastases
Andor W. J. M. Glaudemans et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status
Andrea Romano et al.
EUROPEAN RADIOLOGY (2013)
Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme
Leonard Sunwoo et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Quantitative Imaging in Cancer Evolution and Ecology
Robert A. Gatenby et al.
RADIOLOGY (2013)
Pathologic Diagnosis of Recurrent Glioblastoma: Morphologic, Immunohistochemical, and Molecular Analysis of 20 Paired Cases
Jang-Hee Kim et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Addressing Diffuse Glioma as a Systemic Brain Disease With Single-Cell Analysis
Felix Sahm et al.
ARCHIVES OF NEUROLOGY (2012)
Impact of Intraoperative Stimulation Brain Mapping on Glioma Surgery Outcome: A Meta-Analysis
Philip C. De Witt Hamer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas
Changho Choi et al.
NATURE MEDICINE (2012)
Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma
Elana S. Tykocinski et al.
NEURO-ONCOLOGY (2012)
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging
Ramon F. Barajas et al.
NEURO-ONCOLOGY (2012)
Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging
Won-Jin Moon et al.
NEURORADIOLOGY (2012)
Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group
Michael A. Vogelbaum et al.
NEUROSURGERY (2012)
Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
Matija Snuderl et al.
CANCER CELL (2011)
Molecular imaging of gliomas with PET: Opportunities and limitations
Christian la Fougere et al.
NEURO-ONCOLOGY (2011)
Diffusion MR Imaging: An Important Tool in the Assessment of Brain Tumors
L. Celso Hygino da Cruz et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2011)
The Risk of Getting Worse: Surgically Acquired Deficits, Perioperative Complications, and Functional Outcomes After Primary Resection of Glioblastoma
Sasha Gulati et al.
WORLD NEUROSURGERY (2011)
Glioblastoma Multiforme Regional Genetic and Cellular Expression Patterns: Influence on Anatomic and Physiologic MR Imaging
Ramon F. Barajas et al.
RADIOLOGY (2010)
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
et al.
NEUROSURGERY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Apparent diffusion coefficient and cerebral mood volume in brain gliomas: Relation to tumor cell density and tumor microvessel density based on seterotactic biopsies
N. Sadeghi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
FET PET for the evaluation of untreated gliomas:: correlation of FET uptake and uptake kinetics with tumour grading
Gabriele Poepperl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas
K Torii et al.
ANNALS OF NUCLEAR MEDICINE (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
